FreeAgent c4f9fc8e6ebc2bc5a45082664ef21aa2d72f7c11 false No description of principal activity 20 January 2025 31 January 2026 161935712025-01-202026-01-31 16193571uk-bus:Director12025-01-202026-01-31 16193571uk-bus:AuditExempt-NoAccountantsReport2025-01-202026-01-31 16193571uk-bus:Micro-entities2025-01-202026-01-31 16193571uk-bus:FullAccounts2025-01-202026-01-31 16193571uk-bus:PrivateLimitedCompanyLtd2025-01-202026-01-31 16193571uk-bus:RegisteredOfficeuk-countries:UnitedKingdom2025-01-202026-01-31 161935712025-01-20 161935712026-01-31 16193571uk-core:CurrentFinancialInstruments2026-01-31 16193571uk-core:Non-currentFinancialInstruments2026-01-31 iso4217:GBP xbrli:pure

Dr. Torres Advanced Aesthetics / Arellano Torres Ltd

Unaudited financial statements for the period from 20 January 2025 to 31 January 2026


Company information

Dr. Torres Advanced Aesthetics / Arellano Torres Ltd is a private company limited by shares, registered in England and Wales, registered number 16193571.

The company's registered office is: 18 Old Iron Way, Boston, PE21 9EQ, United Kingdom.

Balance Sheet

as at 31 January 2026

13 months to
31 Jan 26
£ £
Current assets 16,366.95
Creditors: amounts falling due within one year (3,363.12)
Net current assets / (liabilities) 13,003.83
Total assets less current liabilities 13,003.83
Net assets 13,003.83
Capital and reserves 13,003.83

For the period from 20 January 2025 to 31 January 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

Directors' responsibilities:

Approved by the board of directors and signed on behalf of the board,

Lucas Arellano Ferrero
30 September 2026

Notes to the accounts

  1. Average number of employees

    During the period the average number of employees was 0.

  2. Director Advances Credits Note

    At 31 January 2026, £16,293.08 was recorded as due from Celia Torres Pradillo, who was a director when the funds were transferred on 17 September 2025. The continuing director considers the transfer to have been unauthorised. No loan agreement, contractual interest rate or repayment schedule has been identified. No amounts were repaid, written off or waived during the period, and the full balance remained outstanding at the year end. The company intends to seek recovery of the funds.